University of Toronto and the UT Innovations Foundation
This article was originally published in Start Up
Executive Summary
Eight years ago, the University of Toronto and the Innovations Foundation instituted a new policy that offered to give up ownership of most technologies to the researchers who invented them, in return for a 25% cut of the researchers' proceeds. The results of the UT's ownership policy and the IF's reorganization have been dramatic; today, UT researchers disclose about 120 inventions a year, roughly two-thirds of them medically related.
You may also be interested in...
Commercializing Rare Disease Therapies Is Getting Tougher
For an industry increasingly dominated by these drugs, commercial programs need to take on the risk once reserved for development.
Paying for Pharmaceutical Value: The Problem of a One-Size-Fits-All Definition
It is a world, at least the US corner of it, in which any common understanding of drug value is confused by opposing incentives – to opacity and transparency, to looking at benefit broadly or narrowly, long-term or short-term: value, in short, to whom?
A Learning Lab For Outcomes-Based Risk-Sharing Agreements
Merck and UnitedHealth's Optum group have partnered to explore various value constructs.